Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
516686
Reference Type
Journal Article
Title
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
Author(s)
Russell, RJ; Kerry, PS; Stevens, DJ; Steinhauer, DA; Martin, SR; Gamblin, SJ; Skehel, JJ
Year
2008
Is Peer Reviewed?
1
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN:
0027-8424
EISSN:
1091-6490
Volume
105
Issue
46
Page Numbers
17736-17741
Language
English
DOI
10.1073/pnas.0807142105
Abstract
The influenza surface glycoprotein hemagglutinin (HA) is a potential target for antiviral drugs because of its key roles in the initial stages of infection: receptor binding and the fusion of virus and cell membranes. The structure of HA in complex with a known inhibitor of membrane fusion and virus infectivity, tert-butyl hydroquinone (TBHQ), shows that the inhibitor binds in a hydrophobic pocket formed at an interface between HA monomers. Occupation of this site by TBHQ stabilizes the neutral pH structure through intersubunit and intrasubunit interactions that presumably inhibit the conformational rearrangements required for membrane fusion. The nature of the binding site suggests routes for the chemical modification of TBHQ that could lead to the development of more potent inhibitors of membrane fusion and potential anti-influenza drugs.
Keywords
crystallography; drug design; conformational-change; receptor-binding; a viruses; ph; oseltamivir; amantadine; neuraminidase; glycoprotein; infectivity; emergence
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity